Suppr超能文献

慢性肝病中的心肺并发症

Cardiopulmonary complications in chronic liver disease.

作者信息

Moller Soren, Henriksen Jens H

出版信息

World J Gastroenterol. 2006 Jan 28;12(4):526-38. doi: 10.3748/wjg.v12.i4.526.

Abstract

Patients with cirrhosis and portal hypertension exhibit characteristic cardiovascular and pulmonary hemodynamic changes. A vasodilatatory state and a hyperdynamic circulation affecting the cardiac and pulmonary functions dominate the circulation. The recently defined cirrhotic cardiomyopathy may affect systolic and diastolic functions, and imply electromechanical abnormalities. In addition, the baroreceptor function and regulation of the circulatory homoeostasis is impaired. Pulmonary dysfunction involves diffusing abnormalities with the development of the hepatopulmonary syndrome and portopulmonary hypertension in some patients. Recent research has focused on the assertion that the hemodynamic and neurohumoral dysregulation are of major importance for the development of the cardiovascular and pulmonary complications in cirrhosis. This aspect is important to take into account in the management of these patients.

摘要

肝硬化和门静脉高压患者表现出典型的心血管和肺血流动力学变化。一种影响心脏和肺功能的血管舒张状态和高动力循环主导着血液循环。最近定义的肝硬化性心肌病可能影响收缩和舒张功能,并暗示存在机电异常。此外,压力感受器功能和循环稳态调节受损。肺功能障碍包括一些患者出现肝肺综合征和门肺高压时的弥散异常。最近的研究集中在这样一种观点上,即血流动力学和神经体液调节失调对于肝硬化患者心血管和肺部并发症的发生至关重要。在这些患者的管理中考虑这一方面很重要。

相似文献

1
Cardiopulmonary complications in chronic liver disease.
World J Gastroenterol. 2006 Jan 28;12(4):526-38. doi: 10.3748/wjg.v12.i4.526.
2
Splanchnic and systemic hemodynamic derangement in decompensated cirrhosis.
Can J Gastroenterol. 2001 Feb;15(2):94-106. doi: 10.1155/2001/603012.
3
[Hyperdynamic circulation in patients with liver cirrhosis and portal hypertension].
Korean J Gastroenterol. 2009 Sep;54(3):143-8. doi: 10.4166/kjg.2009.54.3.143.
4
The pathophysiology of arterial vasodilatation and hyperdynamic circulation in cirrhosis.
Liver Int. 2018 Apr;38(4):570-580. doi: 10.1111/liv.13589. Epub 2018 Jan 15.
5
Clinical implications of the hyperdynamic syndrome in cirrhosis.
Eur J Intern Med. 2014 Nov;25(9):795-802. doi: 10.1016/j.ejim.2014.09.004. Epub 2014 Sep 20.
6
Circulating nitric oxide products do not solely reflect nitric oxide release in cirrhosis and portal hypertension.
Liver Int. 2011 Oct;31(9):1381-7. doi: 10.1111/j.1478-3231.2011.02576.x. Epub 2011 Jul 5.
7
Mechanisms of extrahepatic vasodilation in portal hypertension.
Gut. 2008 Sep;57(9):1300-14. doi: 10.1136/gut.2007.144584. Epub 2008 Apr 29.
9
Autonomic dysfunction in cirrhosis and portal hypertension.
Scand J Clin Lab Invest. 2008;68(6):437-47. doi: 10.1080/00365510701813096.

引用本文的文献

2
Taurine mitigates cirrhosis-associated heart injury through mitochondrial-dependent and antioxidative mechanisms.
Clin Exp Hepatol. 2020 Sep;6(3):207-219. doi: 10.5114/ceh.2020.99513. Epub 2020 Sep 30.
4
Managing portal hypertension in patients with liver cirrhosis.
F1000Res. 2018 May 2;7. doi: 10.12688/f1000research.13943.1. eCollection 2018.
7
Bioreactance Is Not Interchangeable with Thermodilution for Measuring Cardiac Output during Adult Liver Transplantation.
PLoS One. 2015 May 27;10(5):e0127981. doi: 10.1371/journal.pone.0127981. eCollection 2015.
9
Cirrhotic cardiomyopathy: a cardiologist's perspective.
World J Gastroenterol. 2014 Nov 14;20(42):15492-8. doi: 10.3748/wjg.v20.i42.15492.
10
Diastolic dysfunction and severity of cirrhosis in nonalcoholic cirrhotic patients.
Int J Hepatol. 2013;2013:892876. doi: 10.1155/2013/892876. Epub 2013 Nov 26.

本文引用的文献

1
Portopulmonary hypertension and the issue of survival.
Liver Transpl. 2005 Sep;11(9):1026-7. doi: 10.1002/lt.20494.
2
Hemodynamic features and impaired arterial oxygenation in patients with portopulmonary hypertension.
Hepatol Res. 2005 Jun;32(2):79-88. doi: 10.1016/j.hepres.2005.01.018. Epub 2005 Jun 22.
3
Circulatory function and hepatorenal syndrome in cirrhosis.
Hepatology. 2005 Aug;42(2):439-47. doi: 10.1002/hep.20766.
5
Cardiac, neuroadrenergic, and portal hemodynamic effects of prolonged aldosterone blockade in postviral child A cirrhosis.
Am J Gastroenterol. 2005 May;100(5):1110-6. doi: 10.1111/j.1572-0241.2005.41060.x.
6
Natural history of hepatopulmonary syndrome: Impact of liver transplantation.
Hepatology. 2005 May;41(5):1122-9. doi: 10.1002/hep.20658.
8
Bosentan therapy for portopulmonary hypertension.
Eur Respir J. 2005 Mar;25(3):502-8. doi: 10.1183/09031936.05.00080804.
9
Carboxyhemoglobin levels in cirrhotic patients with and without hepatopulmonary syndrome.
Gastroenterology. 2005 Feb;128(2):328-33. doi: 10.1053/j.gastro.2004.11.061.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验